MoneyWorks4Me

Pfizer concludes acquisition of Hospira

05 Sep 2015 Evaluate

Pfizer has completed its acquisition of Hospira, Inc. on September 03, 2015, creating a leading Global Established Pharmaceutical (GEP) Business. Hospira is the world’s leading provider of injectable drugs and infusion technologies and a global leader in biosimilars.

Pfizer has produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections.


Peers
Company Name CMP
Sun Pharma. Inds. 1850.80
Dr. Reddys Labs. 1216.60
Cipla 1382.10
Lupin 2101.00
Zydus Lifesciences 1171.95
View more..